 |
MSD highlights cholesterol-cardiac relationshipMSD, a leading global biopharmaceutical company, recently held an event with regional medical professionals to focus on the relationship between cholesterol and cardiovascular diseases across Saudi Arabia, and the wider region. Du More… |
 |
Cervical cancer focus for MSD forumMSD, a leading global biopharmaceutical company, recently hosted a round-table in Dubai,UAE to address the rising issue of the Human Papillomavirus (HPV) and the increasing risk of cervical cancer in the Mena region. The event, at More… |
 |
Julphar-MSD partnership wins top ASAP awardJulphar, one of the largest pharmaceutical manufacturers in the Middle East and Africa (MEA), has won the Association of Strategic Alliance Professionals (ASAP) award for 2018 along with its alliance partner, MSD. MSD (known More… |
 |
MSD unveils new resources for diabetes patientsMSD, known as Merck in the US and Canada, has launched new interactive and educational resources to help people with type 2 diabetes in the Middle East who choose to fast during Ramadan. ‘The Facts About Fasting Durin More… |
 |
Julphar in deal to produce, market MSD drugsMSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region. More… |
|
Julphar in deal to produce, market MSD drugsMSD, a global healthcare firm, and Julphar, a UAE-based pharmaceutical company, have signed a five-year agreement, which provides Julphar with exclusive rights to produce, market, distribute and sell certain MSD medicines in the region. More… |
 |
MSD launches new fertility treatmentMSD, a global healthcare leader, has launched its new fertility treatment Elonva (Corifollitropin alfa) in Kuwait bringing new hope to thousands of couples across the country. Already a global issue, infertility affects an estimat More… |
 |
MSD offers new treatment for hepatitis CMSD, a global healthcare leader, today launched a new hepatitis C treatment that could provide a life line to thousands of UAE citizens. Up to 2 per cent of the UAE population suffers from hepatitis C, with many of them failing to be succe More… |
 |
Type 2 diabetics 'face higher heart disease risk'Cardiovascular diseases are the number one killer among Type 2 diabetes patients, according to a research by global healthcare major MSD. MSD presented its latest diabetes research and development insights during the Congress of the Intern More… |
 |
MSD launches new CRM platformMSD Egypt, a healthcare leader, has launched the MSD Connect platform, a Customer Relationship Management (CRM) system. The system helps to organise, automate and synchronise business processes and customer interactions, it said. M More… |
